🐋 CRWD $7M Aggressive Lit Call Buy — Paid Up Through the Ask for ≈16% OTM December Upside 🚀
📅 July 14, 2026 | 🔥 Unusual Activity Detected
🎯 The Quick Take
Someone just paid $7.0 MILLION for CrowdStrike December $240 calls at 12:33:41 ET — and they didn't wait around for a good price, they paid up through the ask to get filled. That's a proven aggressive buy, not a guess, not a lean off a negotiated cross. With CRWD at $207.50 (fresh off its July 2 four-way stock split) and the strike sitting ≈16% higher, this is a real, verified bet that CrowdStrike keeps climbing through two earnings prints and the Fal.Con conference before December 18th. Translation: this is the cleanest bullish signal in today's flow — no guesswork required.
📊 Company Overview
CrowdStrike Holdings (CRWD) is the AI-native leader in cloud-delivered endpoint and cybersecurity, built around its single-agent Falcon platform:
- Market Cap: ≈$205 Billion (post-split; ≈1.02B shares outstanding)
- Industry: Cybersecurity / Security Software
- Current Price: ≈$208.20 (spot at trade time: $207.50)
- Primary Business: Falcon cloud/endpoint security, identity protection, cloud security posture management, SIEM, and — increasingly — Charlotte AI agentic security tooling
- Corporate Action Note: CRWD completed a 4-for-1 stock split on July 2, 2026, resetting the pre-split ≈$770 handle into today's ≈$190–$208 range. That's why a $240 strike now looks "only" ≈16% away instead of the pre-split-equivalent ≈$960.
💰 The Option Flow Breakdown
The Tape (July 14, 2026 @ 12:33:41 ET):
| Time | Symbol | Buy/Sell | Type | Expiration | Premium | Strike | Volume | OI | Size | Spot | Option Price | Option Symbol |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12:33:41 | CRWD | BUY | CALL $240 | 2026-12-18 | $7.0M | $240 | 2,800 | 965 | 2,789 | $207.50 | $25.10 | CRWD20261218C240 |
Flow-Type Tag: ⚡ AGGRESSIVE LIT BUY — this printed on the open, displayed book at 100% across the NBBO, meaning the buyer paid all the way up through the offer to get filled. That's the strongest, most reliable directional tell there is: real liquidity got taken, by a real buyer, in real time.
✅ RESOLVED — Next-Day OI Confirms a Clean Fresh Open (updated July 15, 2026 pre-market)
The July 15 pre-market OPRA snapshot (reflecting end-of-day July 14) is in, and it confirms this was a clean fresh open — essentially 100% brand-new contracts:
| Leg | Baseline OI (EOD 7/13) | Resolving OI (EOD 7/14) | Δ | Size | Verdict |
|---|---|---|---|---|---|
| $240 CALL (Dec-2026) | 965 | 3,761 | +2,796 | 2,789 | ✅ OPEN confirmed (OI rose by essentially the full printed size — a genuine opening long, not a close) |
Verdict: BTO — a fresh opening call buy, exactly as read. OI climbed from 965 to 3,761, a +2,796 increase against a 2,789-lot print — that is as clean a "new bullish position" confirmation as the tape gives. Nothing inverted; the aggressive-open read held.
🤓 What This Actually Means — Plain English
Here's the translation:
- 💸 They paid UP, not just paid: "100% across the NBBO" means the buyer didn't wait for a better price on a resting bid — they lifted the offer. When you see that combined with real depth getting consumed, it's the clearest proof available that someone WANTED this position badly enough to pay the going rate, not haggle for it.
- 🎯 Strike is ≈16% OTM: At $207.50 spot, the $240 strike needs CrowdStrike to rally roughly 16% just to reach the strike, and further still (to ≈$265.10, factoring in the $25.10 premium paid) to reach breakeven at expiration. This is a leveraged, directional bet on a real move higher — not an income play, not a hedge. Calls bought this far out of the money only pay off with genuine appreciation.
- 📅 December 18 expiration spans TWO earnings prints: Fiscal Q2 FY27 earnings land ≈September 2, 2026, and fiscal Q3 FY27 (historically late November/early December) could print just days before this option expires. The buyer gave themselves multiple shots at a positive catalyst, plus the Fal.Con user conference (typically September) as a bonus event risk.
- 🏦 Order type: Given the fresh-open size signal AND the proven lit-aggressor mechanism, this reads as a straightforward BTO (Buy To Open) — Long Call. This is about as clean a directional signal as options flow gets: no cross, no auction, no ambiguity about who took the liquidity.
- ⚖️ What we can't know: OPRA doesn't tell us who bought this, whether it's part of a bigger book (stock, other options, a hedge on something else entirely), or their true conviction level. One $7M call buy from an anonymous account is a data point, not a crystal ball — but it's a genuinely bullish data point, verified at the tape level.
Unusual Score context: This is a real seven-figure premium commitment on a name that just underwent a stock split (thinner recent options history at these strikes makes size stand out more) — not an everyday print, but also not the kind of 1,000x-average outlier that shows up once a year. Think "a desk with real conviction," not "someone fat-fingered a trade."
📈 Technical Setup / Chart Check-Up
YTD Performance Chart

CrowdStrike's 2026 story is dominated by the re-acceleration narrative: fiscal Q1 FY27 (reported June 3) showed net-new ARR up ≈32% YoY — a clear inflection from the post-outage drag of 2024–2025 — and the stock has been rewarded for it, culminating in the July 2 four-for-one split that reset the chart onto a friendlier retail-accessible price scale.
Key observations:
- 📈 Re-acceleration story intact: Ending ARR ≈$5.51B (+24% YoY), net-new ARR guide raised ≈520bp for FY27
- ✂️ Fresh post-split chart: Only two weeks of split-adjusted trading history as of this print — expect some noise in technical levels until the new range establishes itself
- 🛡️ Outage overhang fading: Gross retention held ≈97% through the July 2024 incident recovery; the ≈$60M customer-incentive program has now ended
- 🎯 Street chasing the AI-security multiple: Analyst targets moving up toward and past the $240 strike (UBS $235, Benchmark $230)
Gamma-Based Support & Resistance Analysis

Current Price: $208.20
🔵 Support Levels (Put/Net Gamma Below Price):
- $205 — Moderate support, ≈$4.0B net gamma (≈1.5% below spot)
- $200 — Strong support, ≈$4.5B net gamma (≈3.9% below spot) — the round-number floor dealers will defend hardest
🟠 Resistance Levels (Call/Net Gamma Above Price):
- $210 — Moderate resistance, ≈$3.0B net gamma (≈0.9% above spot) — the closest overhead ceiling
- $212.5 — Moderate resistance, ≈$3.6B net gamma (≈2.1% above spot)
What this means for traders: CRWD is boxed into a genuinely TIGHT gamma range right now — $205–$212.5 — which is typical for a stock just two weeks post-split, as open interest hasn't yet built up at the newer, farther-out strikes like $240. That $240 strike sits well beyond any current gamma wall, meaning the market has to do real technical work (breaking $210, then $212.5, then further) before this new call position starts mattering to dealer hedging flows. It's early-innings for a $240 target — a genuinely multi-month, catalyst-dependent bet.
Implied Move Analysis

Options market pricing for upcoming expirations:
- 📅 Monthly OPEX (Jul 17 — 3 days): ±6.4% (±$13.25) → Range: $194.99 – $221.49
- 📅 Weekly (Jul 24 — 10 days): ±10.5% (±$21.91) → Range: $186.33 – $230.15
- 📅 Quarterly Triple Witch (Sep 18 — 66 days, spans Q2 earnings): ±28.3% (±$58.85) → Range: $149.39 – $267.09
- 📅 Triple Witch (Dec 18 — THIS TRADE'S EXPIRATION): Extrapolated range ≈$123.34 – $293.14
Translation for regular folks: The options market is pricing a modest ±6.4% wobble into Thursday's weekly expiration, but by September — which captures the Q2 earnings report — the priced-in range balloons to ±28.3%, or roughly $149 to $267. Notice that the upper end of that September range ($267) already clears the $240 strike with room to spare. By December, the extrapolated upper bound climbs to ≈$293 — meaning the market itself thinks a move well past $240 is plausible, not a moonshot. That context is exactly why paying $25.10 for this call wasn't reckless: the strike sits comfortably inside the market's own implied cone for the expiration date, not out past it.
Key insight: The jump from a ±6.4% weekly move to a ±28.3% quarterly move reflects real earnings-event uncertainty baked into September pricing — the same uncertainty this $240 call buyer is positioned to benefit from if it resolves to the upside.
🎪 Catalysts
✅ Recent Catalysts (Last 3 Months)
Fiscal Q1 FY27 Earnings — June 3, 2026 (Re-acceleration Confirmed) 📊
CrowdStrike delivered revenue up ≈26% YoY to ≈$1.39B, with ending ARR reaching ≈$5.51B (+24% YoY) and net-new ARR of ≈$255.8M, up ≈32% YoY — a clean inflection versus the post-outage trough. Management raised FY27 net-new-ARR growth guidance to ≈27.7% at the midpoint, a ≈520bp acceleration, while reaffirming free-cash-flow margin of at least 30% for the year. The quarter also posted record operating cash flow ≈$591M and record free cash flow ≈$468M.
4-for-1 Stock Split — Effective July 2, 2026 ✂️
Announced alongside Q1 results, the split reset the pre-split ≈$770 handle into today's ≈$190–$208 range to broaden retail accessibility — directly explaining why a $240 strike, which would have been an eye-watering ≈$960 pre-split, now looks like a reasonable ≈16% OTM leap.
Charlotte AI AgentWorks Launch — March 25, 2026 🤖
CrowdStrike launched its Charlotte AI AgentWorks ecosystem at RSA 2026, a no-code platform for building and orchestrating security agents, with launch partners including AWS, NVIDIA, OpenAI, and Anthropic — positioning CRWD as the security layer for the agentic-AI enterprise.
Falcon Flex Momentum 🚀
The Falcon Flex account-value cohort reached ≈$1.69B ending ARR, up more than ≈120% YoY, and CrowdStrike extended the model to services — this is the land-and-expand engine pulling customers onto more Falcon modules.
Analyst Target Upgrades 📈
UBS raised its target to ≈$235 (from ≈$198), reiterating Buy on AI-security upside. Benchmark lifted its target to ≈$230 (from ≈$195), citing AIDR, Falcon Flex, and identity/SIEM strength. Stifel sits at ≈$220. Consensus across ≈43 covering analysts is Buy — several Street targets already sit at or above the $240 strike this trade is positioned for.
🔮 Upcoming Catalysts (Next 6 Months)
Fiscal Q2 FY27 Earnings — ≈September 2, 2026 (Confirmed, After Close) 🔥
The single most important pre-December catalyst. Watch for confirmation of the net-new-ARR acceleration guided to ≈27.7% at the midpoint, whether the ≈$11M/quarter outage-incentive drag is fully gone, and Falcon Flex/Charlotte AI expansion metrics. This lands squarely inside the Sep 18 triple-witch window and roughly 66 days from today — well before this trade's December expiration.
Fiscal Q3 FY27 Earnings — Estimated Late November/Early December 2026 📅
Historically CrowdStrike's Q3 print lands in this window — potentially just days before the Dec-18 expiry this call is riding. A strong number here could be the direct, late-breaking catalyst that pushes the stock toward $240.
Fal.Con User Conference — Typically September 🎤
CrowdStrike's annual conference has historically been a venue for product launches and large-deal announcements that move the stock — another event risk inside this option's window.
🎲 Price Targets & Probabilities
Using gamma levels, implied-move data, and the catalyst calendar through December 18th expiration:
📈 Bull Case (30% probability)
Target: $240–$265+ (strike and beyond)
Both Q2 and Q3 FY27 earnings beat, net-new ARR confirms the guided ≈27.7% acceleration, Charlotte AI/Falcon Flex adoption metrics impress, and Street targets (already at $230–$235) get pushed further above the $240 strike. September's implied-move upper bound ($267) already reaches this zone — it's a real, priced-in possibility, not a moonshot.
🎯 Base Case (45% probability)
Target: $210–$235 (steady grind higher, strike not quite reached by Dec expiry)
Solid-but-not-spectacular execution: ARR acceleration continues at a normal pace, no major surprises from either earnings print, and the stock drifts toward but doesn't decisively clear $240 by mid-December. In this scenario, the $240 calls likely retain meaningful extrinsic value (especially after a Q2 beat) but may not be deep in the money at expiration.
📉 Bear Case (25% probability)
Target: $185–$205 (back toward or below support)
A soft Q2 ARR guide, renewed Microsoft-bundling pressure narrative, or a broader tech pullback drags CRWD back toward the $200–$205 gamma support zone. In this case the $240 calls likely expire worthless or near-worthless — the buyer loses some or all of the $25.10/share premium ($7.0M total).
🧑🤝🧑 Reader Interpretations — What This Means For YOU
🎲 YOLO Trader
This is your kind of signal: a proven, aggressive, lit-tape call buy — not a mushy cross that could mean anything. If you want to ride the same thesis, the Dec $240 calls (or a cheaper, shorter-dated September call around $230–$240 to line up with the Q2 print) let you piggyback with defined risk. Just remember: this buyer risked $7M knowing they could lose it all if CRWD stalls below $240 by December — size your position so a full loss doesn't wreck your account. Consider a smaller clip in the September expiration to get a cleaner read on the Q2 earnings catalyst without carrying December's added Q3/Fal.Con event risk.
📈 Swing Trader
The real actionable level here is the $210–$212.5 gamma resistance zone just overhead. A confirmed break above $212.5 on strong volume would be the technical confirmation that lines up with this bullish flow — that's your entry signal, not the option print itself. Target the $220–$230 area into the September earnings window, with a stop back below $205 (the nearest real gamma support) if the breakout fails.
💵 Premium Collector
Chasing this specific call isn't your setup — but the flow does tell you where a bull thinks the ceiling might realistically sit. If you already own CRWD shares, consider a covered call at the $240 strike for a similar December date: you'd be selling into the same level this trader is betting on, collecting rich premium on a stock the market's implied move already prices as capable of reaching, while capping upside exactly where the smart-money bet expects resistance to eventually matter.
🌱 Beginner
Here's the lesson in plain terms: this trader paid real money ($25.10 per contract) to bet that CrowdStrike will be meaningfully HIGHER — above $240, not just up a little — by December 18. That's called a "long call," and it's a leveraged bet: if CRWD stays flat or falls, this entire $7.0M could be lost. If you're new to options, the safer way to express the same bullish view is simply owning CRWD shares outright, or buying a call much closer to the current price ($210–$215) with less time-value risk, rather than jumping straight to a far-OTM, multi-month bet like this one.
⚠️ Risk Factors
Don't get caught by these potential landmines:
-
🎯 This is a leveraged, all-or-nothing-ish bet: The $240 strike needs a genuine ≈16% rally just to reach breakeven territory, and further to $265.10 to fully offset the premium paid. If CrowdStrike merely drifts sideways through December, this entire $7.0M premium is at risk of expiring worthless.
-
💸 Valuation offers little cushion: CRWD trades at a rich multiple, and several 12-month analyst targets cluster near or slightly below spot — a Q2 miss or a soft ARR guide could compress that multiple quickly.
-
🏢 Microsoft is the structural overhang: Microsoft's ≈$37B security business bundles Defender/Sentinel into existing M365 E5 agreements at low incremental cost — a pricing pressure pure-play vendors like CrowdStrike can't fully offset with best-of-breed efficacy alone.
-
🩹 Outage overhang isn't fully zero: The July 2024 outage's reputational tail risk still lingers, and the incentive roll-off (≈$11M/quarter) modestly clouds year-over-year optics for another quarter or two.
-
🤖 Agentic-AI monetization is still early: Charlotte AI / AgentWorks adoption must convert into measurable ARR to justify the AI-security re-rating the Street is currently pricing in — this is a "prove it" story, not a done deal.
-
⏳ What the tape CANNOT prove: We know WHO took the liquidity in the sense of "an aggressive buyer" — but not their identity, whether this is part of a larger book (stock, other options, an unrelated hedge), their true conviction, or whether they'll hold to expiration versus trim early. A single $7M call buy — even a proven aggressive one — is one data point, not a guarantee.
-
📊 Fresh post-split options market: With only two weeks of split-adjusted trading, open interest and gamma structure at strikes like $240 are still thin and building — levels could shift meaningfully as more positioning accumulates.
🎯 The Bottom Line
Real talk: This is the cleanest bullish signal in today's options flow, full stop. Someone paid $7.0 million to buy CrowdStrike December $240 calls, and they proved it by paying all the way up through the ask on the lit, displayed market — no cross, no auction, no ambiguity about direction. That's a real, verified bet that CrowdStrike clears its current levels by a meaningful margin over the next five months.
What this trade tells us:
- 🎯 A real buyer wanted CRWD upside badly enough to take liquidity, not wait for a discount
- 📅 They structured it to span BOTH fiscal Q2 (≈Sept 2) and likely Q3 (late Nov/early Dec) earnings, plus Fal.Con
- 📊 The strike ($240) sits inside — not beyond — the market's own September implied-move upper bound ($267), meaning this isn't a hopeless moonshot
- ✅ RESOLVED (July 15 pre-market): the next-day OI print confirmed the fresh open — OI 965 → 3,761 (+2,796 vs. a 2,789-lot print). The opening-long read held.
This is not proof CrowdStrike WILL hit $240 — it's proof someone real, with real money, is betting it will.
If you own CRWD:
- ✅ This flow doesn't change your thesis, but it's a useful confirmation that institutional sentiment leans bullish into earnings season
- 📊 Watch the $210–$212.5 gamma resistance zone as your near-term "is the breakout real" tell
- 🛡️ Consider covered calls near $240 if you want to collect premium on the same level this trade is targeting
If you're watching from the sidelines:
- ⏰ September 2nd (Q2 earnings) is the first major confirmation/denial point for this thesis
- 🎯 A confirmed break above $212.5 gamma resistance would be technical confirmation lining up with this bullish flow
- 📈 Multiple catalysts (two earnings + Fal.Con) inside the December window mean this thesis gets several chances to prove out — or fail — before expiration
Mark your calendar — Key dates:
- 📅 July 17 — Monthly OPEX (weekly implied move window)
- 📅 ≈September 2 (after close) — Fiscal Q2 FY27 earnings — the big one
- 📅 September 18 — Quarterly triple witch
- 📅 ≈Late November/Early December — Estimated Fiscal Q3 FY27 earnings
- 📅 December 18, 2026 — This trade's expiration
Final verdict: CrowdStrike's re-acceleration story is real and confirmed by the tape — ARR growth reaccelerating, outage drag fading, Falcon Flex and Charlotte AI providing genuine expansion vectors, and now a genuinely aggressive, proven $7M call buy betting the stock keeps climbing through year-end. The risk/reward here is a real leveraged bet, not a sure thing — size accordingly, and let the next-day OI check and September earnings do the confirming.
Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance doesn't guarantee future results. The mechanism read on this trade (aggressive lit buy, 100% across NBBO) is proven from the real options tape; the buyer's identity, full portfolio context, and ultimate conviction are not knowable from the tape alone. Always do your own research and consider consulting a licensed financial advisor before trading. Earnings and conference catalysts inside this option's window create real event-risk gaps that could move the stock sharply in either direction.
About CrowdStrike Holdings: CrowdStrike Holdings provides AI-native, cloud-delivered endpoint and cybersecurity protection through its Falcon platform, spanning endpoint security, identity protection, cloud security, SIEM, and agentic-AI security tooling, with a market cap of ≈$205 billion in the Security Software industry.
Last updated: July 15, 2026 (pre-market OI resolution — fresh open confirmed, OI 965 → 3,761; thesis unchanged).